Operative management for recurrent and metastatic adrenocortical carcinoma

Journal of Surgical Oncology

Volumn 105, Issue 7, 2012, Pages 709-713

  Datrice, Nicole M ^a   Langan, Russell C ^a   Ripley, R Taylor ^a   Kemp, Clinton D ^a   Steinberg, Seth M ^b   Wood, Bradford J ^a   Libutti, Steven K ^c   Fojo, Tito ^a,d   Schrump, David S ^a   Avital, Itzhak ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

and lung resection; liver resection; metastatic adrenocortical carcinoma

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; GEMCITABINE;

ADOLESCENT; ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; DISEASE FREE INTERVAL; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84859884713     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23015     Document Type: Article

References (20)

1. Schteingart DE, Doherty GM, Gauger PG, et al.: Management of patients with adrenal cancer: Recommendations of an International Consensus Conference. Endocr Relat Cancer 2005; 12: 667-680. (Pubitemid 41483000)
2. Bilimora KY, Shen WT, Elaraj D, et al.: Adrenocortical carcinoma in the United States: Treatment utilization and prognostic factors. Cancer 2008; 113: 3130-3136.
3. Grubbs EG, Callender GG, Xing Y, et al.: Recurrence of adrenal cortical carcinoma following resection: Surgery alone can achieve results equal to surgery plus mitotane. Ann Surg Oncol 2010; 17: 263-270.
4. Wandoloski M, Bussey KJ, Demeure MJ,: Adrenocortical cancer. Surg Clin North Am 2009; 89: 1255-1267.
5. Weiss LM, Medeiros LJ, Vickery AL,: Pathological features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1988; 13: 202-206.
6. Schulick RD, Brennan MF,: Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999; 6: 719-726. (Pubitemid 30013647)
7. Di Carlo I, Toro A, Sparatore F, et al.: Liver resection for hepatic metastases from adrenocortical F carcinoma. HPB 2006; 8: 106-109.
8. Icard P, Chapuis Y, Adnreeassian B, et al.: Adrenocortical carcinoma in surgically treated patients: A retrospective study on 156 cases by the French Association of Endocrine Surgeons. Surgery 1992; 112: 972-980. (Pubitemid 23008221)
9. Polat B, Fassnacht M, Pfreundner L, et al.: Radiotherapy in adrenocortical carcinoma. Cancer 2009; 115: 2816-2823.
10. Wood BJ, Abraham J, Hvizda JL, et al.: Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 2003; 97: 554-560. (Pubitemid 36125832)
11. Ripley RT, Kemp CD, Davis JL, et al.: Liver Resection and ablation for metastatic adrenocortical carcinoma. Ann Surg Oncol 2011; 18: 1972-1979.
12. Haak HR, Hermans J, van de Velde CJ, et al.: Optimal treatment of adrenocortical carcinoma with mitotane: Results in a consecutive series of 96 patients. Br J Cancer 1994; 69: 947-951. (Pubitemid 24140681)
13. Cheng YC, Ueno NT,: Improvement of survival and prospect of cure in patients with metastatic breast cancer. Breast Cancer 2011 May 13. [Epub ahead of print]. PMID 21567170.
14. Leong SP, Nakakura EK, Pollock R, et al.: Unique patterns of metastases in common and rare types of malignancy. J Surg Oncol 2011; 103: 607-614.
15. Soreide JA, Braband K, Thoresen SO,: Adrenal cortical carcinoma in Norway, 1970-1984. World J Surg 1992; 16: 663-668.
16. Zografos GC, Driscoll DL, Karakousis CP, et al.: Adrenal adenocarcinoma: A review of 53 cases. J Surg Oncol 1994; 55: 160-164. (Pubitemid 24096516)
17. Crucitti F, Bellantone R, Ferrante A, et al.: The Italian Registry for Adrenal Cortical Carcinoma: Analysis of a multiinstitutional series of 129 patients. Surgery 1996; 119: 161-170.
18. Wooten MD, King DK,: Adrenal cortical carcinoma. Cancer 1993; 72: 3145-3355.
19. Pommier MF, Brennan MF,: An eleven-year experience with adrenocortical carcinoma. Surgery 1992; 122: 963-971. (Pubitemid 23008220)
20. Luton J, Cerdas S, Line B, et al.: Clincal features of adrenocortical carcinoma, prognostic factors, the effect of mitotane therapy. NEJM 1990; 322: 1195-1201. (Pubitemid 20137851)